Epithelial ovarian cancer is primarily a disease of older women. Advanced age is risk factor for decreased survival. Optimal surgery and the safe and effective administration of chemotherapy are essential for prolonged progression-free and overall survival (OS). In this article, the available regimens in both the primary treatment and relapsed setting are reviewed.
Keywords: Ovarian cancer; carboplatin; chemotherapy; elderly; geriatrics; intraperitoneal; paclitaxel.